Literature DB >> 24903329

Antibody detection in tear samples as a surrogate to monitor host immunity against papillomavirus infections in vaccinated and naturally infected hosts.

Jiafen Hu1, Sarah Brendle1, Karla Balogh1, Stephanie Bywaters1, Neil Christensen2,1.   

Abstract

Monitoring serum antibodies against natural infections or after immunizations has been a standard clinical diagnostic procedure. However, collecting blood samples requires trained personnel, and may cause discomfort and increase the risk of complications. In this study, we investigated whether tear samples could serve as a surrogate for serum samples to measure specific antibodies. A widely used preclinical cottontail rabbit papillomavirus (CRPV)/rabbit model has been a surrogate model for high-risk human papillomavirus (HPV) infections. New Zealand white rabbits, either naturally infected with CRPV or immunized with two clinically available HPV vaccines (Gardasil and Cervarix), were examined for antibody generation in both tear and serum samples. We demonstrated that antibodies were detectable in tears from both naturally infected as well as vaccinated animals. Overall, the antibody levels in tears were ~10-fold lower than those from the corresponding serum samples, but background noise was lower in tear samples. The isotypes of antibodies in tears were predominantly IgA and IgG. These findings showed clearly that tears could be a surrogate for serum samples for monitoring antibody responses. As collecting tears causes no discomfort and poses no risk to patients, it represents a novel and promising method for monitoring future HPV epidemiological studies as well as for use in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903329      PMCID: PMC4135090          DOI: 10.1099/vir.0.064154-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

Review 1.  Detection of antibodies in saliva--an effective auxiliary method in surveillance of infectious diseases.

Authors:  R Madar; S Straka; T Baska
Journal:  Bratisl Lek Listy       Date:  2002       Impact factor: 1.278

Review 2.  Tear analysis in ocular surface diseases.

Authors:  Lei Zhou; Roger W Beuerman
Journal:  Prog Retin Eye Res       Date:  2012-06-23       Impact factor: 21.198

Review 3.  Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.

Authors:  Paul L McCormack; Elmar A Joura
Journal:  BioDrugs       Date:  2011-10-01       Impact factor: 5.807

4.  Anti-HIV-antibodies in tears of patients with AIDS.

Authors:  S Liotet; C Hartmann; L Batellier; C Chaumeil; J Frottier
Journal:  Fortschr Ophthalmol       Date:  1987

Review 5.  Immunology of the tears.

Authors:  M Allansmith
Journal:  Int Ophthalmol Clin       Date:  1973

6.  Cytomegalovirus antibodies in tear fluid of patients with retinitis.

Authors:  E B Rozanova; L E Teplinskaia; A F Kaliberdina; T Barisani-Asenbauer
Journal:  Arch Virol       Date:  2006-07-10       Impact factor: 2.574

7.  Measurement of tear glucose levels with amperometric glucose biosensor/capillary tube configuration.

Authors:  Qinyi Yan; Bo Peng; Gang Su; Bruce E Cohan; Terry C Major; Mark E Meyerhoff
Journal:  Anal Chem       Date:  2011-10-12       Impact factor: 6.986

8.  Impact of genetic changes to the CRPV genome and their application to the study of pathogenesis in vivo.

Authors:  Jiafen Hu; Nancy M Cladel; Karla Balogh; Lynn Budgeon; Neil D Christensen
Journal:  Virology       Date:  2006-10-04       Impact factor: 3.616

9.  Systemic and ocular antibody responses to inactivated acute hemorrhagic conjunctivitis (AHC) virus; enterovirus 70 (EV70).

Authors:  Marlyn P Langford; Rogelio Orillac; Dequan Chen; Donald Texada
Journal:  Ocul Immunol Inflamm       Date:  2003-09       Impact factor: 3.070

10.  Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread.

Authors:  Hannamari Välimaa; Jorma Tenovuo; Matti Waris; Veijo Hukkanen
Journal:  Virol J       Date:  2009-05-12       Impact factor: 4.099

View more
  3 in total

Review 1.  Gene Editing in Rabbits: Unique Opportunities for Translational Biomedical Research.

Authors:  Jie Xu; Jifeng Zhang; Dongshan Yang; Jun Song; Brooke Pallas; Chen Zhang; Jiafen Hu; Xuwen Peng; Neil D Christensen; Renzhi Han; Y Eugene Chen
Journal:  Front Genet       Date:  2021-01-28       Impact factor: 4.599

2.  An excitation wavelength-optimized, stable SERS biosensing nanoplatform for analyzing adenoviral and AstraZeneca COVID-19 vaccination efficacy status using tear samples of vaccinated individuals.

Authors:  Wansun Kim; Soogeun Kim; Jisang Han; Tae Gi Kim; Ayoung Bang; Hyung Woo Choi; Gyeong Eun Min; Jae-Ho Shin; Sang Woong Moon; Samjin Choi
Journal:  Biosens Bioelectron       Date:  2022-02-08       Impact factor: 10.618

3.  SARS-CoV-2 RNA and antibodies in tear fluid.

Authors:  Astrid Muyldermans; Maria Bjerke; Thomas Demuyser; Deborah De Geyter; Ingrid Wybo; Oriane Soetens; Ilse Weets; Robert Kuijpers; Sabine D Allard; Denis Piérard; Peter P M Raus
Journal:  BMJ Open Ophthalmol       Date:  2021-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.